ArticleFrontiers in medicine2021

YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial.

Weiping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.